期刊文献+

非达霉素的分离纯化 被引量:2

Separation and Purifi cation of Fidaxomicin
原文传递
导出
摘要 开发了高纯度非达霉素的分离纯化工艺。采用中压色谱系统,以聚合物微球为载体,优化了微球类型和洗脱条件。结果显示,选用聚合物微球Uni PS 30-300为色谱介质,洗脱剂为75%甲醇(含0.05%乙酸),上样量1.0 g/100 ml填料,纯化所得产品纯度≥95%,纯化收率≥60%。 The separation and purification process of fidaxomicin was developed. A medium pressure chromatography system using polymer microsphere as the carrier was setup. The system was optimized by studying the different types of polymer microsphere and elution conditions. The results showed that when using Uni PS 30- 300 polymer microsphere as the chromatography fi ller, 75% methanol(containing 0.05% acetic acid) as the eluant, and 1.0 g/100 ml fi lter as the sample loading amount, the purity of the fi nal product was higher than 95% and the yield was above 60%.
出处 《中国医药工业杂志》 CAS CSCD 北大核心 2015年第4期351-353,共3页 Chinese Journal of Pharmaceuticals
基金 国家"重大新药创制"科技重大专项(2014ZX09201-001-003)
关键词 非达霉素 聚合物微球 分离纯化 抗菌剂 大环内酯类抗生素 fidaxomicin polymer microsphere separation and purifi cation antibacterial macrolide antibiotics
  • 相关文献

参考文献7

  • 1Parenti F, Pagani H, Beretta G. Lipiarmycin, a new antibiotic from Actinoplanes. I. Description of the producer strain and fermentation Studies [J]. J Antibiot (Tokyo), 1975, 28 (4) : 247-252.
  • 2Coronelli C, White RJ, Lancini GC, et al. Lipiarmycin, a new antibiotic from Actinoplanes. II. Isolation, chemical, biological and biochemical characterization [J]. J Antibiot (Tokyo), 1975, 28(4): 253-259.
  • 3姜春梅,刘洋,王京晶,张清,康博欣.抗感染新药非达霉素的药理作用与临床评价[J].中国新药杂志,2011,20(23):2283-2285. 被引量:17
  • 4马培奇.美FDA咨询委员会推荐批准非达霉素治疗艰难梭菌感染[J].上海医药,2011,32(5):235-235. 被引量:8
  • 5邱友宏,谢TM,罗梅罗A,等.大环多晶型物,包含这类多晶型物的组合物及其使用和制备方法:中国,200880009132.3[P].2008-01-22.
  • 6张长生,李苏梅,牛四文,等.六种台勾霉素类化合物及其制备方法和在制备抗菌药物中的应用:中国,201110104051[P].2011-04-25.
  • 7Shue YK, Gorbach S, Sears P. Treatment of clostridium difficile infection in patients undergoing antibiotic therapy : WO, 2011146621A2 [P]. 2011-09-24.

二级参考文献3

共引文献18

同被引文献6

引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部